405. Synthetic laboratory
Head: KATALIN URAY, Ph.D.
Address: Budapest, Pázmány P. sétány 1/A, 405.
Telefon: 06-1-372-2500
Fax: 06-1-372-2620
Former PhD students:
Hajnalka Szabados (co-supervisor: Szilvia Bősze), 2015
Ádám Bartos (társtémavezető: Ferenc Hudecz), 2009
A Kutatócsoportban készült összes disszertáció listája itt látható
M.Sc. students since 2017:
Dávid Szabó (co-supervisor: Szilvia Bősze)
Bence Széles (co-supervisor: Szilvia Bősze)
Nazrin Tahirzade
Tamkin Aslanki (co-supervisor: Arnold Steckel)
Bendegúz Szekrényes (co-supervisor: Arnold Steckel)
Alina Yerbulekova
B.Sc. students since 2017:
Zsombor Fölker (co-supervisor: Szilvia Bősze)
Anna Krisztina Frisch (co-supervisor: Szilvia Bősze)
Réka Zsuzsanna Szatmári
Dávid Szabó (co-supervisor: Szilvia Bősze)
Domonkos Pál (co-supervisor: Gitta Schlosser)
Zoé Sára Tóth
Kristóf Gábor Battai
Dávid Papp (co-supervisor: Gitta Schlosser)
Dóra Illik (co-supervisor: Szilvia Bősze)
The main activity in the laboratory is the synthesis and purification of peptides for the following aims:
Selective targeting of drugs with HSV-1 gD derived peptides:
Based on the entry mechanism of Herpes simplex virus (HSV) we design peptides selectively entering into fibroblasts, epithelial cells and neurons.
The HSV peptides internatizing efficiently and selectively are conjugated with drugs against intracellular pathogens.
Complement activating peptides for the selective elimination of autoreactive B-cells:
We are preparing the complement activating sequences of the HIV gp120 glycoprotein, which - conjugating to the epitopes of autoreactive B-cells via nanoparticles - are able to selectively eliminate the B-cell population with the given selectivity.
Bence Széles (co-supervisor: Szilvia Bősze)
Nazrin Tahirzade
Tamkin Aslanki (co-supervisor: Arnold Steckel)
Bendegúz Szekrényes (co-supervisor: Arnold Steckel)
Alina Yerbulekova
Anna Krisztina Frisch (co-supervisor: Szilvia Bősze)
Réka Zsuzsanna Szatmári
Dávid Szabó (co-supervisor: Szilvia Bősze)
Domonkos Pál (co-supervisor: Gitta Schlosser)
Zoé Sára Tóth
Kristóf Gábor Battai
Dávid Papp (co-supervisor: Gitta Schlosser)
Dóra Illik (co-supervisor: Szilvia Bősze)
The main activity in the laboratory is the synthesis and purification of peptides for the following aims:
Selective targeting of drugs with HSV-1 gD derived peptides:
Based on the entry mechanism of Herpes simplex virus (HSV) we design peptides selectively entering into fibroblasts, epithelial cells and neurons.
The HSV peptides internatizing efficiently and selectively are conjugated with drugs against intracellular pathogens.
Complement activating peptides for the selective elimination of autoreactive B-cells:
We are preparing the complement activating sequences of the HIV gp120 glycoprotein, which - conjugating to the epitopes of autoreactive B-cells via nanoparticles - are able to selectively eliminate the B-cell population with the given selectivity.
